Tizanidine-structure (Tizanidine Usp 1)
Tizanidine
Product Images NDC 53217-211
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 53217-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Tizanidine-figure1 (Tizanidine Usp 2)
Tizanidine-figure2 (Tizanidine Usp 3)
Tizanidine-figure3 (Tizanidine Usp 4)
The text describes the improvement in Ashworth Score and mentions the mean dose used in the study. It also indicates different time points in the study, including the end of titration, end of maintenance, and the endpoint.*
Package Label (Tizanidine Usp 5)
This is a description for Tizanidine, USP, a medication used to treat muscle spasms. It is contained in a white, round tablet with 503 inscribed on one side and X scored on the reverse. Packaged by Alkaloida Chemical Company ZRT, it is suggested to be taken every 6 to 8 hours with a maximum dose of 36 mg per day. This package is not to be given to children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
